Oct 03, 2023
Lineus Medical® is proud to announce the U.S. Food and Drug Administration (FDA) has cleared its flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, midlines, peripherally inserted central...
Sep 06, 2023
Health Canada has issued a licence on Lineus Medical's flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, peripherally inserted central catheters, central venous catheters, midlines, IV ports,..
May 25, 2023
Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients.
Apr 17, 2023
Lineus Medical continues to expand its distribution network for SafeBreak® Vascular. This time, it's in the veterinary space, with SafeBreak® Vascular Vet.
Apr 13, 2023
Lineus Medical is proud to announce its selection into the 2023 Fuel Accelerator Program.
Feb 08, 2023
Provides the Opportunity to Sell SafeBreak® Vascular in International Markets
Aug 25, 2022
Lineus Medical announces publication of the randomized controlled trial performed at Colorado State University Veterinary Teaching Hospital in the Journal of the American Veterinary Medical Association.
Aug 24, 2022
Lineus Medical continues to expand its patent portfolio with the issuance of two new patents. The first issued patent was a Japanese Utility Patent (JP7095097) for SafeBreak® Vascular, a break-away medical device that helps protect peripheral IV lines.
May 02, 2022
Contract awarded for products that bring improvement to health care industry
Mar 23, 2022
Lineus Medical announces the publication of a pivotal clinical study performed at Hartford Hospital, part of Hartford HealthCare in Hartford, Connecticut, in the March edition of The Journal of Infusion Nursing.